Prevalence of hepatitis C virus among psoriatic patients

The prevalence of dermatologic manifestations related to chronic hepatitis C virus infection

Assessment of interleukin-17 and vitamin D serum levels in psoriatic patients

Serum and in situ expression of transforminggrowth factor beta 1 in Psoriasis

Assessment of CTACK in sera of psoriatic patients, undergoing puva or methotrexate therapy

Serum hepcidin levels in patients with chronic hepatitis C

Serum hepcidin levels in chronic hepatitis C patients

Changes in immunomodulators in relation to interferon therapy in hepatitis c virus infection

Estimation of visfatin in serum and tissue of psoriasis patients

Serum ferritin and reduced glutathione concentrations in chronic hepatitis C patients treated with interferon-alpha